Venkatesan Jay

See Remarks, DirectorAngion Biomedica Corp. (ANGN) · full profile →Form 4/A · filed May 27, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.5M
Net Open-Market Flow
-$2.5M
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 9, 2021Option exercise(X)396K$6.43$2.5M1.6M
Feb 9, 2021Sell(S)159K$16.00$2.5M1.4M
Feb 9, 2021Conversion(C)262$11.57$3K1.4M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 9, 2021Option exercise(X)396K$00

Transaction Codes

X
Exercise of in-the-money derivative
S
Open-market sale
C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001601485-22-000045) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about ANGN insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001601485-22-000045"
Ask your agent
Use Arkolith to summarize insider buying and selling at Angion Biomedica Corp.
over the last 90 days and cite the filings.